How Clear Frameworks Reduce Friction Across Teams

We are not creating the "perfect baby"

When we look at the fine detail of someone's genes, are we stepping somewhere we should not? Are we playing at some kind of design,choosing what a person should be before they are even born?

It is a fair question. And it deserves an honest answer rather than a comfortable one.

I spent the best part of two decades in prenatal genetics.When I started, the testing was narrow, mostly looking for conditions like Down syndrome. Then the techniques grew more powerful. We could see more, and then more again. Today we can read a person's DNA quickly and at reasonable cost and looking at the small changes in our genes has become almost routine. The science moved fast. The questions about what we should do with it moved more slowly, as they always do.

‍

‍

So where does one stop?

Some recent marketing, mostly from across the Atlantic, has promised parents the perfect baby, selected and optimised through genetic prediction. I will be honest. It made me deeply uncomfortable. Partly because it overpromises something that is barely achievable, and the science behind predicting complex traits is far shakier than the marketing suggests. But mostly because of the question hiding underneath it. What is a perfect baby? Who decides? And where is the line between the traits we inherit from the people who made us, which are surely part of what it means to love a child, and the traits we might one day try to select or enhance?

I do not think there is a clean answer. And I think anyone who tells you there is one should be treated with caution.

This is where I want to be clear about what carrier screening actually is, because it is not the same thing at all. Carrier screening looks for serious, life-limiting recessive conditions, the kind where two healthy parents can unknowingly carry the same change and have a one-in-four chance, in each pregnancy, of a child affected by real and often devastating illness. It is not about height, or intelligence, or eye colour, or any notion of an ideal. It is about a narrow set of conditions that cause profound suffering. Even those who defend the more expansive technologies tend to accept that reducing the chance of severe disease sits on very different ground from selecting for desirable traits. The literature draws that line clearly, and so do we.

That does not make the ethics simple

It does not, on its own, silence the objections, and the objections are worth stating properly.

There are people who would rather not know. For some, that comes from faith, a sense that these things are not ours to see or to shape.

For others it is a belief that a life is not diminished by illness or disability, and that to screen against a condition is to say something painful about the people already living with it. That view has real weight, and I have never wanted to argue it away. A person can hear everything I have to say and still choose not to test, and I would want them to leave feeling respected, not judged.

There are also the harder, structural questions. If screening becomes ordinary, does it quietly become expected? Could that pressure ever shade into something coercive? Could it deepen the gap between families who can afford these choices and those who cannot? These are not reasons to stop. They are reasons to stay honest, and to keep the debate in the open rather than pretending it is settled.

Set against all of that is a simpler argument, and I hold it sincerely. There is a real good in sparing families avoidable pain, grief and loss. Not by telling anyone what to decide, but by giving them the knowledge to decide for themselves, early, calmly, from a place of understanding rather than of shock. That is the whole of it. Information, and then the freedom to use it however your own values guide you.

Where we sit is deliberate. We screen for conditions that cause serious, life-limiting disability. Not traits. Not preferences. Not some idea of a better human. That is the line we have drawn, and we hold it carefully.

This will never be an easy subject, and it should not be.There will always be people who see it differently, and that difference is nota problem to be solved. It is the debate itself, and it is a healthy one to keep having.

If I had to guess where the real difficulty lies in the years ahead, it is not in whether we can detect more. We will.

It is in the far harder question of what we should choose to include and what we should have the wisdom to leave alone.